Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Intervention With Tiotropium （Spiriva） in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized, Double-blind, Placebo-controlled, Parallel, Multicentre Trial

NCT01455129 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT01455129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01455129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Intervention With Tiotropium （Spiriva） in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized, Double-blind, Placebo-controlled, Parallel, Multicentre Trial
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2011
Completion date
August 31, 2016
Enrollment
841 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease